Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
about
Advances in umbilical cord blood cell therapy: the present and the future.Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.
P2860
Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Comparison of graft-versus-hos ...... th hematological malignancies.
@en
type
label
Comparison of graft-versus-hos ...... th hematological malignancies.
@en
prefLabel
Comparison of graft-versus-hos ...... th hematological malignancies.
@en
P2093
P2860
P1433
P1476
Comparison of graft-versus-hos ...... ith hematological malignancies
@en
P2093
Arinobu Tojo
Hiroto Ishii
Maki Oiwa-Monna
Satoshi Takahashi
Seiko Kato
P2860
P304
P356
10.3109/10428194.2015.1122784
P577
2016-01-14T00:00:00Z